Evidence map›Paper›PMID 36601302›Full record

ArticleFrontiers in cellular and infection microbiology2022

AUF-1 knockdown in mice undermines gut microbial butyrate-driven hypocholesterolemia through AUF-1-Dicer-1-mir-122 hierarchy.

Oishika Das, Jayanta Kundu, Atanu Ghosh, Anupam Gautam, Souradeepa Ghosh, Mainak Chakraborty, Aaheli Masid, Samiran Sona Gauri, Debmalya Mitra, Moumita Dutta and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Molecular Morbidity Score-Can MicroRNAs Assess the Burden of Disease?International journal of molecular sciences · 2024
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Oishika DasDepartment of Immunology, Indian Council of Medical Research-National Institute of Cholera and Enteric Diseases, Kolkata, India.
Jayanta KunduSchool of Applied and Interdisciplinary Sciences, Indian Associations for Cultivation of Science, Kolkata, India.
Atanu GhoshSchool of Applied and Interdisciplinary Sciences, Indian Associations for Cultivation of Science, Kolkata, India.
Anupam GautamDepartment of Algorithms in Bioinformatics, Institute for Bioinformatics and Medical Informatics, University of Tübingen, Tübingen, Germany.
Souradeepa GhoshSchool of Medical Science and Technology, Indian Institute of Technology, Kharagpur, India.
Mainak ChakrabortyDepartment of Immunology, Indian Council of Medical Research-National Institute of Cholera and Enteric Diseases, Kolkata, India.
Aaheli MasidDepartment of Immunology, Indian Council of Medical Research-National Institute of Cholera and Enteric Diseases, Kolkata, India.
Samiran Sona GauriSchool of Medical Science and Technology, Indian Institute of Technology, Kharagpur, India.
Debmalya MitraDepartment of Immunology, Indian Council of Medical Research-National Institute of Cholera and Enteric Diseases, Kolkata, India.
Moumita DuttaDepartment of Immunology, Indian Council of Medical Research-National Institute of Cholera and Enteric Diseases, Kolkata, India.
Budhaditya MukherjeeSchool of Medical Science and Technology, Indian Institute of Technology, Kharagpur, India.
Surajit SinhaSchool of Applied and Interdisciplinary Sciences, Indian Associations for Cultivation of Science, Kolkata, India.
Moumita BhaumikDepartment of Immunology, Indian Council of Medical Research-National Institute of Cholera and Enteric Diseases, Kolkata, India.
National Institute of Cholera and Enteric Diseases · INIndian Association for the Cultivation of Science · INIndian Institute of Technology Kharagpur · INIndian Council of Medical Research · INUniversity of Tübingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction and objective: Cholesterol homeostasis is a culmination of cellular synthesis, efflux, and catabolism to important physiological entities where short chain fatty acid, butyrate embodied as a key player. This discourse probes the mechanistic molecular details of butyrate action in maintaining host-cholesterol balance. Methods: Hepatic mir-122 being the most indispensable regulator of cholesterol metabolic enzymes, we studied upstream players of mir-122 biogenesis in the presence and absence of butyrate in Huh7 cells and mice model. We synthesized unique self-transfecting GMO (guanidinium-morpholino-oligo) linked PMO (Phosphorodiamidate-Morpholino Oligo)-based antisense cell-penetrating reagent to selectively knock down the key player in butyrate mediated cholesterol regulation. Results: We showed that butyrate treatment caused upregulation of RNA-binding protein, AUF1 resulting in RNase-III nuclease, Dicer1 instability, and significant diminution of mir-122. We proved the importance of AUF1 and sequential downstream players in AUF1-knock-down mice. Injection of GMO-PMO of AUF1 in mouse caused near absence of AUF1 coupled with increased Dicer1 and mir-122, and reduced serum cholesterol regardless of butyrate treatment indicating that butyrate acts through AUF1. Conclusion: The roster of intracellular players was as follows: AUF1-Dicer1-mir-122 for triggering butyrate driven hypocholesterolemia. To our knowledge this is the first report linking AUF-1 with cholesterol biogenesis.

Indexed as

Gastrointestinal MicrobiomeMicroRNAsAnimalsButyratesCholesterolDEAD-box RNA HelicasesHeterogeneous Nuclear Ribonucleoprotein D0MiceRibonuclease IIIButyratesCholesterolDEAD-box RNA HelicasesDicer1 protein, mouseHeterogeneous Nuclear Ribonucleoprotein D0Hnrpd protein, mouseMicroRNAsMirn122 microRNA, mouseRibonuclease IIIAUF-1butyratecholesterol metabolismDicer-1GMO–PMOmicrobiomemir-122.

Identifiers

PMID36601302
PMCPMC9806232
OpenAlexW4313389607

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.